United Kingdom

Milpharm Ltd

Reference: GB-PPON-PCYZ-5538-QLGR

Awards

€3,040,698,154

Total awarded

Recent awards

NHS National Generic Pharmaceuticals - Wave 16a
27 August 2026 · £21,026,178
NHS National Generic Pharmaceuticals - Wave 16a
27 August 2026 · £393,331,872
NHS National Generic Pharmaceuticals - Wave 16a
27 August 2026 · £15,529,352
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
15 June 2026 · £166,347,397
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
15 June 2026 · £665,389,588
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
1 June 2026 · £813,863,584
NHS National Generics Pharmaceuticals - Supply Chain Resilience
1 May 2026 · £35,010,320
NHS National Generics Pharmaceuticals - Supply Chain Resilience
1 May 2026 · £4,213,176
NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide
24 March 2026 · £19,595,208
NHS National Generic Pharmaceuticals - Wave 15c
13 January 2026 · £403,702,000

Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.